The Vioxx debacle revisited.
Daikh
David I
DI
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006801:Humans; D007783:Lactones / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D012941:Social Responsibility; D013450:Sulfones / Q000009:adverse effects*; D014481:United States
D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib